Filters
reset all| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 288 | 218 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
MYO7A - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Invitae United States | 32 | 17 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Inherited Retinal Disorders Panel Invitae United States | 486 | 293 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Myriad Genetics, Inc. United States | 3 | 1 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics, part of Exact Sciences United States | 360 | 222 |
|
Molecular Vision Laboratory United States | 342 | 268 |
|
Baylor Genetics United States | 1 | 1 |
|
Autosomal Dominant Hearing Loss. 25-gene NGS panel. Genologica Medica Spain | 48 | 23 |
|
Non-syndromic hearing loss panel. 95-gene NGS panel. Genologica Medica Spain | 146 | 94 |
|
Leber's congenital amaurosis panel. NGS panel of 26 genes. Genologica Medica Spain | 40 | 26 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
Autosomal recessive hearing loss. 41-gene NGS panel. Genologica Medica Spain | 65 | 41 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 3 | 1 |
|
Hearing Loss, Comprehensive Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 142 | 84 |
|
Deafness, autosomal dominant: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 40 | 39 |
|
Syndromic Hearing Loss NGS Panel Fulgent Genetics United States | 223 | 83 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.